1046P Phase I/II open-label study on an anti-GPC3 T cell engager, SAR444200, in patients with advanced solid tumors: Preliminary dose escalation results

J. Yong Hong,B-Y. Ryoo, M. Chenard-Poirier, K. Almhanna,D.W-T. Lim, J. Samol, G. Abbadessa, R. Meng, S. Masciari, A. Kefsi, Y. Zhang, H. Guillemin-Paveau, B. Pasquier, L. Lepine,E.E. Dumbrava

Annals of Oncology（2023）

引用 0|浏览3

暂无评分

关键词

advanced solid tumors,solid tumors,preliminary dose escalation results,sar444200,open-label,anti-gpc

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要